No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Calcium Channel Blockers / therapeutic use
-
Cardiomyopathy, Restrictive* / complications
-
Cardiomyopathy, Restrictive* / diagnosis
-
Cardiomyopathy, Restrictive* / genetics
-
Cardiomyopathy, Restrictive* / therapy
-
Diagnostic Imaging
-
Diuretics / therapeutic use
-
Heart Failure / etiology*
-
Heart Failure / physiopathology
-
Humans
-
Mutation
-
Prognosis
-
Troponin I / genetics
-
Ventricular Myosins / genetics
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin II Type 1 Receptor Blockers
-
Angiotensin-Converting Enzyme Inhibitors
-
Calcium Channel Blockers
-
Diuretics
-
Troponin I
-
Ventricular Myosins